T50.Z15

Clinical Causes: Incorrect administration of immunoglobulin injections Patient's sensitivity or allergy to immunoglobulin components Contaminated immunoglobulin preparations Pre-existing health conditions increasing risk of reactions Rapid infusion rates leading to adverse responses Immune system overreaction to foreign antibodies Concurrent use of other medications that interact negatively

Key Symptoms: Headache Fever or chills Flushing or skin rash Muscle or joint pain Nausea, vomiting, or diarrhea Breathing difficulties or wheezing Hypotension (low blood pressure) Back or chest discomfort Swelling at the injection site Anaphylactic reactions in severe cases

Diagnosis Path: The diagnosis of adverse effects from immunoglobulin use is primarily clinical, based on observing symptoms following treatment administration. Healthcare providers might conduct laboratory tests to rule out other causes and to determine the severity of the reaction. A detailed medical history, including previous reactions and allergies, is essential. Monitoring vital signs during and after infusion helps detect early signs of adverse responses. In some cases, allergen-specific testing may be performed to identify sensitivities.

Treatment Protocols: Management of adverse effects involves immediate supportive care tailored to the severity of the reaction. Mild symptoms such as headache or nausea may resolve with reassurance, hydration, and symptomatic treatments. Severe reactions, including anaphylaxis, require emergency interventions such as epinephrine administration, oxygen therapy, and antihistamines. Adjusting infusion rates or premedicating with antihistamines or corticosteroids can help prevent future reactions. Healthcare providers may also review the immunoglobulin product batch for contamination and consider alternative formulations or routes of administration if necessary. Post-reaction monitoring is critical to ensure complete recovery and to plan for future treatments safely.